Poseida Therapeutics, Inc.

New Filing
CIK: 0001661460·Biotechnology·DELAWARE·Filed: Apr 3, 2018
Total Offering

$30,499,990

Amount Sold

$30,499,990

Investors

7

First Sale

Mar 19, 2018

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2014
Non-Accredited Investors
No

Related Persons

NameRole
Eric Ostertag
Related Person
Mark Gergen
Related Person
Adrian Howd
Related Person
David Hirsch
Related Person

Company

Poseida Therapeutics, Inc.

4242 Campus Point Court, Suite 700

San Diego, CA, 92121

858-779-3100

SEC Filing

0001661460-18-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free